Overall survival of patients with relapsed multiple myeloma treated with panobinostat or placebo plus bortezomib and dexamethasone (the PANORAMA 1 trial): a randomised, placebo-controlled, phase 3 trial.
暂无分享，去创建一个
M. Dimopoulos | H. Einsele | S. Lonial | W. Jędrzejczak | P. Richardson | J. H. Lee | P. Moreau | Sung-Soo Yoon | J. Hou | R. Schlossman | J. San-Miguel | V. Hungria | A. Elghandour | A. Günther | T. N. Nakorn | N. Siritanaratkul | M. Sopala | B. Bengoudifa | F. Binlich | M. Beksaç | S. Yoon